Your browser doesn't support javascript.
loading
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Chang, Margaret A; Kapre, Audrey; Kaufman, Derrick; Kardatzke, David R; Rabena, Melvin; Patel, Shienal; Bobbala, Ashwini; Gune, Shamika; Fung, Anne; Wallenstein, Gene.
Affiliation
  • Chang MA; Retinal Consultants, Sacramento, California.
  • Kapre A; Genentech, Inc, South San Francisco, California.
  • Kaufman D; Genentech, Inc, South San Francisco, California.
  • Kardatzke DR; Genentech, Inc, South San Francisco, California.
  • Rabena M; Genentech, Inc, South San Francisco, California.
  • Patel S; Genentech, Inc, South San Francisco, California.
  • Bobbala A; Genentech, Inc, South San Francisco, California.
  • Gune S; Genentech, Inc, South San Francisco, California.
  • Fung A; Genentech, Inc, South San Francisco, California.
  • Wallenstein G; Genentech, Inc, South San Francisco, California.
JAMA Ophthalmol ; 140(8): 771-778, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35708706
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Year: 2022 Type: Article